| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-7095 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-18 |
| filingDate |
2011-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2012-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20120128413-A |
| titleOfInvention |
Three-Dimensional Crystal Structure of NLP3 PD and Drug Screening Method Using the Same |
| abstract |
The present invention relates to a three-dimensional crystal structure of NALP3 PYD, a crystallization method thereof, and a drug screening method using the same, and screens a drug based on the third structure of the NALP3 PYD protein using the three-dimensional crystal structure of the NALP3 PYD. Information can be provided and screened for NALP3 PYD protein inhibitors. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160091483-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200011272-A |
| priorityDate |
2011-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |